Drugs Similar to IMUFLEX WB-RP BLOOD BAG SYSTEM WITH INTEGRAL WHOLE BLOOD LEUKOCYTE REDUCTION FILTER (REMOVING PLATELETS) WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRESERVATIVE
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE CPD AND AS 5 RED CELL PRESERVATIVE
Related medications based on brand, generic name, substance, active ingredients.
By Generic Name
Drugs with the same generic name (different brands)
/ PRODUCT SPECIFICATIONS 11.1. This blood bag system includes a 16 gauge x 1 1/2 inch (1.60 × 38 mm) needle with needle cover and a 500mL (nominal capacity 600mL) collection bag containing 70mL Citrate Phosphate Dextrose (CPD) anticoagulant. The Quadruple blood bag set has one integrally attached empty primary bag, one empty XT-612 5 day Platelet bag, and one satellite bag containing 111 mL OPTISOL Red Cell Preservative Solution. 11.2. Blood bag codes ending in A6 are the collection set with an Integral Diversion Blood Sampling Arm for obtaining donor samples prior to collection of the Whole Blood Unit. 11.3. Blood bag codes ending in A6 also include a DonorCareTM Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side. 11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer). 11.5. The blood bag has no components made of natural rubber latex. 11.6. Tubing internal diameter (ID) nominal 3.0 mm. 11.7. Tubing outer diameter (OD) nominal 4.4 mm. 11.8. Tubing line maximum 16 segments available.
The Reveos SELECT set has been evaluated for use with the Reveos system. The blood and fluid pathways of the blood bag set are steam-sterilized and are non-pyrogenic. The blood bag set is intended for use by appropriately trained phlebotomists who collect whole blood and by blood center personnel who process whole blood using the Reveos system. The formulas of the active ingredients are provided in Tables 1 and 2. Table 1: CPD Active Ingredients Ingredients Molecular Formula Molecular Weight Dextrose (anhydrous) C 6 H 12 O 6 180.16 g/mol Trisodium Citrate (dihydrate) C 6 H 5 Na 3 O 7 2H 2 O 294.10 g/mol Citric Acid (monohydrate) C 6 H 8 O 7 H 2 O 210.14 g/mol Sodium Dihydrogen Phosphate (dihydrate) NaH 2 PO 4 2H 2 O 156.01 g/mol Water for Injection H 2 O 18.02 g/mol Each 70 mL of CPD contains: Dextrose (anhydrous) 1.624 g, Trisodium Citrate (dihydrate) 1.841 g, Citric Acid (monohydrate) 0.229 g, Sodium Dihydrogen Phosphate (dihydrate) 0.176 g, and water for injection up to 70 mL. Table 2: AS-5 Active Ingredients Ingredients Molecular Formula Molecular Weight Dextrose (anhydrous) C 6 H 12 O 6 180.16 g/ mol Sodium Chloride NaCl 58.44 g/mol Mannitol C 6 H 14 O 6 182.17 g/mol Adenine C 5 H 5 N 5 135.13 g/mol Water for injection H 2 O 18.02 g/mol Each 111 mL of AS-5 contains: Dextrose (anhydrous) 0.908 g, Sodium Chloride 0.973 g, Mannitol 0.583 g, Adenine 0.035 g, and water for injection up to 111 mL. The PVC plasticized with DEHP bags are not made with natural rubber latex. The bags contain materials that have been tested to demonstrate the suitability of the containers for storing pharmaceutical solutions. The bags are nontoxic and biologically inert. The blood bag set is a closed system and is not dependent upon entry of external air during administration. The blood bag set is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.